Skip navigation
Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z
Prevention Among Injection Drug Users
 IDU HIV Prevention

Archive archive

 IDU Home
 Fact Sheets:
 Syringe Disinfection
 Sterile Syringes
 Viral Hepatitis
 Subst. Abuse
Treatment
 Criminal Justice
 Order Printed Materials
 Dear Colleague Letters
 Other Publications
 Comprehensive
Approach
 Brochure
 Document
 Safe Community Syringe Disposal
Explore IDU Topics
Comments
  Legend
Link to a PDF document Link to a PDF document
Link to a Non-CDC site
Link to non-CDC site or document and does not necessarily represent the views of CDC
Adobe Acrobat (TM) Reader needs to be installed on your computer in order to read documents in PDF format. Download the Reader.
U.S. Department of Health and Human Services

Archival Content: 1999-2005

HIV Prevention Among Drug Users:
A Resource Book for Community Planners & Program Managers


Appendix D: Bibliography

Appendix D provides a bibliography listing all references used in developing the HPDU Resource Book. Information on how to acquire these and other materials and information can be found in PART 5: RESOURCES.

Abdul-Quader AS, Friedman SR, Des Jarlais D, Marmor MM, Maslansky R, Bartelme S. Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemporary Drug Problems 1987;14:425-34.

Academy for Educational Development (AED). Handbook for HIV prevention community planning. Washington (DC): Academy for Educational Development; 1994. Contract No.: 200-91-0906. Funding provided by the Centers for Disease Control and Prevention.

Academy for Educational Development (AED). What intervention studies say about effectiveness: a resource for HIV Prevention Community Planning groups. Washington (DC): Academy for Educational Development: 1996 May. Contract No.: 200-91-0906. Funding provided by the Centers for Disease Control and Prevention.

Alexander P. Sex work, AIDS, and the law. Testimony before the National Commission on AIDS; 1992.

American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition. Washington, DC: American Psychiatric Association, 1994.

Anglin M, Hser Y, McGlothlin W. Sex differences in addict careers: 2, becoming addicted. American Journal of Drug and Alcohol Abuse 1987;13(1-2):59-71.

Anglin MD, Speckart GR, Booth MW. Consequences and costs of shutting off methadone. Addictive Behaviors 1989;14(3):307-26.

Ball JC, Meyers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior 1988;29(3):214-26.

Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag; 1991.

Bandura A. Social cognitive theory and exercise of control over HIV infection. In: DiClemente RJ, Peterson JL, editors. Preventing AIDS: theories and methods of behavioral interventions. New York: Plenum Press; 1994.

Battjes RJ, Slobada Z, Grace WC, editors. National Institute on Drug Abuse research monograph 143: the context of HIV risk among drug users and their sexual partners. Rockville (MD): National Institute on Drug Abuse; 1994. NIH Publication No. 94-3750.

Birkel RC, Golaszewski T, Koman JJ 3rd, Singh BK, Catan V, Souply K. Findings from the Horizontes Acquired Immune Deficiency Syndrome Education Project: the impact of indigenous outreach workers as change agents for injection drug users. Health Education Quarterly 1993;20(4):523-538.

Blair JF, Hein KK. Public policy implications of HIV/AIDS in adolescents. The Future of Children 1994;4(3):73-93.

Bortolotti F, Bertaggia A, Cadrobbi P, Crivellaro C, Pronaro E, Realdi G. Epidemiological aspects of acute viral hepatitis in drug abusers. Infection. 1982;10(5):277-279.

Calsyn DA, Meinecke C, Saxon AJ, Stanton V. Risk reduction in sexual behavior: a condom giveaway program in a drug abuse treatment clinic. American Journal of Public Health 1992;82(11):1536-1538.

Caplehorn JRM, Ross MW. Methadone maintenance and the likelihood of risky needle sharing. International Journal of Addictions 1995;30(6):685-98.

Center for AIDS Prevention Studies (CAPS). CAPS factsheet: what are sex workers' HIV prevention needs? 1996 April.

Centers for Disease Control and Prevention (CDC). 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. MMWR Morbidity and Mortality Weekly Report 1992;41(RR-17):1-19.

Centers for Disease Control and Prevention (CDC). AIDS associated with injection drug use - United States, 1995. MMWR Morbidity and Mortality Weekly Report 1996;45:392-398.

Centers for Disease Control and Prevention (CDC). Antibody to human immunodeficiency virus in female prostitutes. MMWR Morbidity and Mortality Weekly Report 1987;36(11):157-161.

Centers for Disease Control and Prevention (CDC). HIV/AIDS surveillance report 1995;7(2).

Centers for Disease Control and Prevention (CDC). HIV/AIDS surveillance report 1996;8(1).

Centers for Disease Control and Prevention (CDC). Community level prevention of human immunodeficiency virus infection among high-risk populations: the AIDS community demonstration projects. MMWR Morbidity and Mortality Weekly Report 1996;45(RR-6):1-24.

Centers for Disease Control and Prevention (CDC). Public Health Service interagency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Morbidity and Mortality Weekly Report 1991;40(RR-4):1-15.

Centers for Disease Control and Prevention (CDC). National HIV serosurveillance summary: results through 1992, vol. 3. Atlanta: U.S. Department of Health and Human Services; 1994a.

Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance. Atlanta: US Department of Health and Human Services; 1994b.

Centers for Disease Control and Prevention (CDC), Division of HIV/AIDS Prevention; Council of State and Territorial Epidemiologists. Suggested guidelines for developing an epidemiologic profile for HIV prevention community planning. Atlanta (GA): Centers for Disease Control and Prevention; 1995 June.

Chamot E, de Saussure PH, Hirschel B, Deglon JJ, Perrin LH. Incidence of hepatitis C, hepatitis B, and HIV infections among drug users in a methadone-maintenance programme (letter). AIDS 1992;6(4):430-431.

Chiasson MA, Stoneburner RL, Hildebrandt DS, Ewing WE, Telzak EE, Jaffe HW. Heterosexual transmission of HIV-1 associated with the use of smokable freebase cocaine (crack). AIDS 1991;5(9):1121-1126.

Chirgwin K, DeHovits JA, Disson S, McCormack WM. HIV infection, genital ulcer disease, and crack cocaine use among patients attending a clinic for sexually transmitted diseases. American Journal of Public Health 1991;81(12):1576-1579.

Chitwood DD, McCoy CB, Inciardi JA, McBride DC, Comberford M, Trapido E, McCoy HV, Page JB, Griffin J, Fletcher MA. HIV seropositivity of needles from shooting galleries in South Florida. American Journal of Public Health 1990;80(2):150-152.

Choi KH, Coates, TJ. Preventing HIV infection. AIDS 1994;8(10):1371-1389.

Cohen JB. Why women partners of drug users will continue to be at high risk for HIV infection. Journal of Addiction Diseases 1991;10(4):99-110.

Committee on Social and Behavioral Sciences. Evaluating HIV prevention programs. Washington (DC): National Academy Press; 1992.

Compton WM, Cottler LB, Decker SH, Magner D, Stringfellow R. Legal needle buying in St. Louis. American Journal of Public Health 1992;82(4):595-596.

Cournos F, Empfield M, Horwath E, McKinnon K, Meyer I, Schrage H, Currie C, Agosin B. HIV seroprevalence among patients admitted to two psychiatric hospitals. American Journal of Psychiatry 1991;148(9):1225-1230.

Coyle SL (NOVA Research Company, Bethesda, MD). The NIDA HIV counseling and education intervention model: intervention manual. Rockville (MD): National Institutes of Health; 1993. Contract No.: 271-90-8407.

DeLeon G. Residential therapeutic communities in the mainstream: diversity and issues. Journal of Psychoactive Drugs 1995;27(1):3-15.

DeLeon G. The therapeutic community: study of effectiveness. Treatment Research Monograph 84-1286. Rockville (MD): National Institute on Drug Abuse; 1984.

Deren S, Davis WR, Beardsley M, Tortu S, Clatt S. Outcomes of a risk reduction intervention with high risk populations: the Harlem AIDS Project. AIDS Education and Prevention 1995;7(5):379-390.

Des Jarlais DC. The effectiveness of AIDS prevention efforts. New York: Beth Israel Medical Center; 1995 June.

Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection - results of a randomized trial prevention program. British Journal of Addiction 1992;87(3):493-498.

Des Jarlais DC, Friedman SR, Sotheran JL, Wenston J, Marmor M, Yancovitz SR, Frank B, Beatrice S, Mildvan D. Continuity and change within an HIV epidemic. JAMA 1994;271(2):121-127.

Des Jarlais DC , Friedman SR, Ward TP. Harm reduction: A public health response to the AIDS epidemic among injecting drug users. Annual Review of Public Health 1993;14:413-450.

Diaz T, Chu SY. Crack cocaine use and sexual behavior among people with AIDS [letter]. JAMA 1993;269(22):2845-2846.

Diaz T, Chu SY, Byers RH Jr, Hersh BS, Conti L, Rietmeijer CA , Mokotoff E, Fann SA, Boyd D, Iglesias L, et al. The types of drugs used by HIV-infected drug users in a multistate surveillance project: implications for intervention. American Journal of Public Health 1994;84(12):1971-1975.

Donoghoe MC. Sex, HIV and the injecting drug user. British Journal of Addiction 1992;87(3):405-416.

Edlin BR, Irwin KL, Faruque S, McCoy CB, Word C, Serrano Y, Inciardi JA, Bowser BP, Schilling RF, Holmberg SD. Intersecting epidemics: crack cocaine use and HIV infection among inner-city young adults. New England Journal of Medicine 1994;331(21):1422-1427.

El-Bassel N, Ivanoff A, Schilling RF, Gilbert L, Borne D, Chen DR. Preventing HIV/AIDS in drug-abusing incarcerated women through skills building and social support enhancement: preliminary outcomes. Social Work Research 1995;10(3):131-141.

Ellerbrock TV, Harrington PE, Bush TJ, Schoenfisch SA, Oxtoby MJ, Witte JJ. Risk of human immunodeficiency virus infection among pregnant crack cocaine users in a rural community. Obstetrics & Gynecology 1995;86(3):400-404.

Elwood WN. Lipstick, needle, and company: a case study of the structure of a bridge group in Houston, Texas. Connections 1995;April:18.

Finkelstein N. Treatment issues for alcohol and drug-dependent pregnant and parenting women. Health and Social Work 1994;19(1):7-15.

Fischer PJ, Breakey WR. The epidemiology of alcohol, drug, and mental disorders among homeless persons. American Psychologist 1991;46:1115-1128.

Fishbein M, Bandura A, Triandis HC, Kanfer FH, Becker M, Middlestadt SE. Factors influencing behavior and behavior change. Final report prepared for the NIMH Theorists' Workshop. Washington (DC): 1993.

Fishbein M, Middlestadt SE. Using the theory of reasoned action as a framework for understanding and changing AIDS-related behaviors. In: Mays VM, Albee G W, Schneider SF, editors. Primary prevention of AIDS: psychological approaches. Newbury Park (CA): Sage Publications; 1989.

Fisher B, Hovell M, Hofstetter CR, Hough R. Risks associated with long-term homelessness among women: battery, rape, and HIV infection. International Journal of Health Services. 1995;25(2):351-369.

Friedman SR. Promising social network research results and suggestions for a research agenda. In: Needle RH, Coyle SL, Genser SG, Trotter RT, editors. National Institute on Drug Abuse research monograph 151: social networks, drug abuse, and HIV transmission. Rockville (MD): National Institute on Drug Abuse; 1995. NIH Publication No. 95-3889.

Friedman SR, Des Jarlais DC, Ward TP, Jose B, Neaigus A, Goldstein M. Drug injectors and heterosexual AIDS. In Sherr L, editor. AIDS and the heterosexual population. Chur (Switzerland): Harwood Academic Publishers; 1993.

Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. American Journal of Epidemiology 1995;142(8):864-874.

Friedman SR, Neaigus A, Des Jarlais DC, Sotheran JL, Woods J, Sufian M, Stepherson B, Sterk C. Social intervention against AIDS among injecting drug users. British Journal of Addiction 1992;87(3):393-404.

Friedman SR, Jose B, Neaigus A, Goldstein M, Curtis R, Iledefonso G, Mota P, Des Jarlais DC. Consistent condom use in relationships between seropositive injecting drug users and sex partners who do not inject drugs. AIDS 1994;8(3):357-361.

Friedman SR, Sotheran JL, Abdul-Quader A, Primm BJ, Des Jarlais JC, Kleinman P, Mauge C, Goldsmith DS, el-Sadr W, Maslansky R. The AIDS epidemic among Blacks and Hispanics. Milbank Quarterly 1987;65(Suppl 2):455-499.

Gay Men's Health Crisis. Harm reduction and steps towards change: a training source book. New York: Gay Men's Health Crisis; 1994.

Gerstein DR, Harwood HJ, editors. (Institute of Medicine). Treating drug problems: volume 1, a study of the evolution, effectiveness, and financing of public and private drug treatment systems. Washington (DC): National Academy Press; 1990.

Greer P, Dickinson G, Parra F, Eqea F, Jordahl L, Homes R. HIV seropositivity in a clinic for homeless. VII International Conference on AIDS; Montreal, Canada, 1989 June 4-9:50(abstract no. M.A.O. 28).

Grund JP, Heckathorn DD, Broadhead RS, Anthony DL. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. Journal of AIDS and Human Retrovirology 1995;10(1):104-105.

Hammett T. 1992 update: HIV/AIDS in correctional facilities. As cited in: Center for AIDS Prevention Studies (CAPS). What are inmates' HIV prevention needs. 1995 August.

Hartel D. Context of HIV risk behavior among female injecting drug users and female sexual partners of injecting drug users. In: Battjes RJ, Sloboda Z, Grace WC, editors. National Institute on Drug Abuse research monograph 143: the context of HIV risk among drug users and their sexual partners. Rockville (MD): National Institute on Drug Abuse; 1994. NIH Pub. No. 95-3750.

Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health 1996;86(5):642-654.

Holtgrave DR, Qualls NL, Curran JW, Valdiserri RO, Guinan ME, Parra WC. An overview of the effectiveness and efficiency of HIV prevention programs: an overview. Public Health Reports 1995;110(2):134-146.

Hser YI, Anglin MD, Booth MW. Sex differences in addict careers: 3, addiction. American Journal of Drug and Alcohol Abuse 1987;13(3):231-251.

Hu DJ, Fleming PL, Mays MA, Ward JW. The expanding regional diversity of the acquired immunodeficiency syndrome epidemic in the United States. Archives of Internal Medicine 1994;154(6):654-659.

Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: a national study of effectiveness. Chapel Hill, N.C.: University of North Carolina Press, 1989.

Inciardi JA, Lockwood D, Pottieger AE. Women and crack cocaine. New York: Macmillan Publishing Company; 1993.

Inciardi JA, Page J. Drug sharing among intravenous drug users. AIDS 1991;5(6):772-773.

Institute of Medicine, National Academy of Sciences (IOM). Assessing the social and behavioral science base for HIV/AIDS prevention and intervention: workshop summary. Washington (DC): National Academy Press; 1995.

Janz NK, Zimmerman MA, Wren PA, Israel BA, Freudenberg N, Carter RJ. Evaluation of 37 AIDS prevention projects: successful approaches and barriers to program effectiveness. Health Education Quarterly 1996;23(1):80-97.

Johnson, Bassin, and Shaw, Inc. (Silver Spring, MD). Epidemiologic trends in drug abuse, volume I: highlights and executive summary. Rockville (MD): National Institute on Drug Abuse, Division of Epidemiology and Prevention Research; 1995 June. NIH Publication No. 95-3990.

Johnson, Bassin, and Shaw, Inc. (Silver Spring, MD). Epidemiologic trends in drug abuse, volume II: community epidemiology work group, proceedings. Rockville (MD): National Institute on Drug Abuse, Division of Epidemiology and Prevention Research; 1995 June. NIH Publication No. 96-3991.

Johnson LD, O'Malley PM, Bachmen J (University of Michigan, Ann Arbor, MI). National survey results on drug use from the monitoring the future study 1975-1994, volume 1, secondary school students. Rockville (MD): National Institute on Drug Abuse; 1995.

Kail BL, Watson DD, Ray S. Needle using practices within the sex industry. American Journal of Drug and Alcohol Abuse. 1995;21(2):241-255.

Kaplan J. HIV, heroin, and heterosexual relations. Social Science and Medicine 1983;32(9):1037-1050.

Kelly JA. AIDS prevention: strategies that work. The AIDS Reader 1992;July/August:135-141.

Koblin BA , McCusker J, Lewis BF, Sullivan JL. Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study. American Journal of Epidemiology 1990:132(5);837-846.

Koester S, Hoffer L. Indirect sharing: additional HIV risks associated with drug injection. AIDS & Public Policy Journal 1994;9(2):100-105.

Latkin C, Mandell W, Vlahov D. A personal network approach to AIDS prevention: an experimental peer group intervention for street-injecting drug users: the SAFE study. In: Needle RH, Coyle SL, Genser SG, Trotter RT, editors. National Institute on Drug Abuse research monograph 151: social networks, drug abuse, and HIV transmission. Rockville (MD): National Institute on Drug Abuse; 1995. NIH Publication No. 95-3889.

Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE study. American Journal of Community Psychology 1996;24(3):341-364.

Legal Action Center. Manual on confidentiality of patient records for alcohol and other drug treatment programs for communication and collaboration between AOD and public health systems. Prepared for the Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration, PHS.

Levine OS, Vishov D, Brookmeyer R, Cohn S, Nelson KE. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users. Journal of Infectious Diseases 1996;173(3):579-583.

Lurie P, Reingold AL, Bowser B, Chen D, Foley J, Guydish J, Kahn JG, Lane S, Sorensen J, et al. (University of California, Berkeley, School of Public Health; University of California, San Francisco, Institute for Health Policy Studies). The public health impact of needle exchange programs in the United States and abroad, volume 1. Berkeley (CA): The Regents of the University of California; 1993. Prepared for the Centers for Disease Control and Prevention.

Malow RM, West JA, Corrigan SA, Pena JM, Cunningham SC. Outcome of psycho-education for HIV risk reduction. AIDS Education and Prevention 1994;6(2):113-125.

Mandell W, Vlahov D, Latkin C, Oziemkwska M, Cohn S. Correlates of needle sharing among injection drug users. American Journal of Public Health 1994;84(6):920-923.

Martinez, B (Executive Office of the President, Office of National Drug Control Policy). Letter to: ONDCP Bulletin No. 7: Needle exchange programs, are they effective? 1992 July.

Marx R, Aral SO, Rolfs RT, Sterk CE, Kahn JG. Crack, sex, and STD. Sexually Transmitted Diseases 1991;18(2):92-101.

Mata AG, Jorquez JS. Mexican-American intravenous drug users' needle sharing practices: implications for AIDS prevention. In: May VM, Albee GW, Schneider SF (editors). Primary prevention of AIDS; psychological approaches. Newbury Park (CA): Sage Publications; 1989.

McCoy CB, Shapshak P, Shah SM, McCoy HV, Rivers JE, Page JB, Chitwood DD, Weatherby NL, Inciardi JA, McBride DC, Mash DC, Watters JK. HIV-1 prevention: interdisciplinary studies and reviews on efficacy of bleach and compliance to bleach prevention protocols. In: Proceedings, workshop on needle exchange and bleach distribution programs. Washington (DC): National Academy Press; 1994.

McLellan AT, Alterman AI, Metzger DS, Grissom G, Woody GE, Luborsky L, O'Brien CP. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. Journal of Consulting and Clinical Psychology 1994;62(6):1141-58.

Metzger DS. Drug abuse as AIDS prevention. Paper prepared for the National Institute for Health Conference on Interventions to Prevent HIV Risk Behaviors, Feb.11-13, 1997.

Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, De-Philippis D, Stolley P, Abrutyn E. Human immunodeficiency virus seroconversion among in-and out-of-treatment intravenous drug users: an 18-month prospective follow up. Journal of Acquired Immune Deficiency Syndromes 1993;6(9):1049-1056.

Miller HG, Turner CF, Moses LE, editors (National Research Council). AIDS: the second decade. Washington (DC): National Academy Press; 1990.

Moos RH. Evaluating treatment environments. New York: Wiley; 1974.

Moos RH, Finney JW, Cronkite RC. Alcoholism treatment: context, process and outcome. New York: Oxford University Press; 1990.

Moss AR, Vranizan K, Gorter R, Bachetti P, Watters J, Osmond D. HIV seroconversion in intravenous drug users in San Francisco: 1985-1990. AIDS 1994;8(2):223-231.

Murphy S, Waldorf D. Kicking down to the street doc: shooting galleries in the San Francisco Bay Area. Contemporary Drug Problems 1991;28(1):9-29.

National Commission on AIDS. Behavioral and social sciences and the HIV/AIDS epidemic. Washington (DC): National Commission on AIDS; 1993.

National Commission on AIDS. The twin epidemics of substance use and HIV. Washington (DC): National Commission on AIDS; 1991 July.

National Institute for Drug Abuse (NIDA). AIDS and intravenous drug use: future directions for community-based prevention research. Washington (DC): National Institute on Drug Abuse; 1990.

National Institutes of Health (NIH). National Institutes of Health Consensus Development Statement: interventions to prevent HIV risk behaviors. 1997 Feb 11-13; Bethesda (MD): National Institutes of Health; 1997.

Needle RH, Coyle SL, Genser SG, Trotter RT, editors. National Institute on Drug Abuse research monograph #151: social networks, drug abuse, and HIV transmission. Rockville (MD): National Institute on Drug Abuse; 1995. NIH Publication No. 95-3889.

Normand J, Vlahov D, Moses LE, editors (National Research Council and Institute of Medicine). Preventing HIV transmission: the role of sterile needles and bleach. Washington (DC): National Academy Press; 1995.

Nyamathi AM, Flaskerus J, Bennett C, Leake B, Lewis C. Evaluation of two AIDS education programs for impoverished Latina women. AIDS Education and Prevention 1994;6(4)296-309.

Novick DM, Joseph H, Croxon TS, Salsitz EA, Wang G, Richman BL, Pretsky L, Keefe JB, Whimbey E. Absence of antibody to human immunodeficiency virus in long term, social rehabilitated methadone maintenance patients. Archives of Internal Medicine 1990;150(1):97-99.

Padian, NS, Wijgert J, O'Brien TR. Interventions for sexual partners of HIV infected or high-risk individuals. In: DiClemente RJ, Peterson JL, editors. Preventing AIDS: theories and methods of behavioral interventions. New York: Plenum Press; 1994.

Paone D, Caloir S, Shi Q, Des Jarlais DC. Sex, drugs, and syringe exchange in New York City: women's experiences. Journal of the American Medical Women's Association (JAMWA) 1995;50(3-4):109-114.

Pickens RW, Leukefeld CG, Schuster CR, editors. Improving drug abuse treatment, research monograph 106. Rockville (MD): National Institute on Drug Abuse; 1991. DHHS publication no.: (ADM) 91-1754.

Polonsky S, Kerr S, Harris B, Gaiter J, Fichtner RR, Kennedy MG. HIV prevention in prisons and jails: obstacles and opportunities. Public Health Reports 1994;109(5):615-625.

Prevots DR, Allen DM, Lehman JS, Green TA, Petersen LR, Gwinn M. Trends in human immunodeficiency virus seroprevalence among injection drug users entering drug treatment centers, United States, 1988-1993. American Journal of Epidemiology 1996;143(7):733-742.

Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. American Psychologist 1992;47:1102-1114.

Ratner M, editor. Crack pipe as pimp: an ethnographic investigation of sex-for-crack exchanges. New York: Lexington Books; 1993.

Ray O, Ksir C. Drugs, society and human behavior. St. Louis: Mosby Yearbook, Inc.; 1996.

Reed BG. Drug misuse and dependency in women: the meaning and implications of being considered a special population or minority group. International Journal of Addictions 1985;20(1):13-62.

Rhodes F, Corby NH, Wolitski RJ, Tashima N, Crain C, Yankovich DR, Smith PK. Risk behaviors and perceptions of AIDS. Journal of Drug Education 1990;20(4):271-288.

Rietmeijer CA, Kane MS, Simons PZ, Corby NH, Wolitski RJ, Higgins DL, Judson FN, Cohn DL. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted community-level HIV prevention program. AIDS 1996;10(3):291-298.

Rogers E. Diffusion of innovations. New York: Free Press; 1983.

Rosenberg PS. Scope of the AIDS epidemic in the United States. Science 1994;270:1372-1375.

Rosenstock IM, Strecher VJ, Becker MH. The health belief model and HIV risk behavior change. In: DiClemente RJ, Peterson JL, editors. Preventing AIDS: theories and methods of behavioral interventions. New York: Plenum Press; 1994.

Saxon A, Calsyn DA, Whittaker S, Freeman G. Sexual behavior of intravenous drug users in treatment. Journal of Acquired Immune Deficiency Syndromes 1991;4(10):938-944.

Schilling RF, El-Bassel N, Schinke SP, Gordon K, Nichols S. Building skills of recovering women drug users to reduce heterosexual AIDS transmission. Public Health Reports 1991;106(3):297-304.

Schilling RF, et al. Correlates of drug use, sexual behavior, and attitudes toward safer sex among African American and Hispanic women in methadone maintenance. Journal of Drug Issues 1991;21:685-698.

Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny K, Rogers M, Feiner C, Friedland G. Risk factors for human immunodeficiency virus infection in intravenous drug users. New England Journal of Medicine 1989;321(13):874-879.

Schutt RK, Garrett GR. Responding to the homeless: policy and practice. New York: Plenum; 1992.

Selwyn PA , Batki SL, consensus panel co-chairs. Treatment for HIV-infected alcohol and other drug abusers, treatment protocol (TIP) series 15. Rockville (MD): Center for Substance Abuse Treatment; 1995. DHHS Publication No.: (SMA) 95-3038.

Serpelloni G, Carriere MP, Rezza G, Morganti S, Gomma M, Binkin N. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-controlled study. AIDS Care 1994;6(2):215-220.

Siegal HA, Falck RS, Carlson RG, Wang J. Reducing HIV needle risk behaviors among injection-drug users in the Midwest: an evaluation of the efficacy of standard and enhanced intervention. AIDS Education and Prevention 1995;7(4):308-319.

Simpson D, Savage L. Drug abuse treatment readmissions and outcomes. Archives of General Psychiatry 1980;37:896-901.

Sorensen JL, London J, Heizmann C, Gibson DR, Morales ES, Dumontet R, Acree M. Psychoeducational group approach: HIV risk reduction in drug users. AIDS Education and Prevention 1994;6(2):95-112.

Sorensen JL, Wermuth LA, Gibson DR, Choi KH, Guydish JR, Batki SL. Preventing AIDS in drug users and their sexual partners. New York: Guildford Press; 1991.

St. Lawrence JS, Brasfield TL. HIV risk behavior among homeless adults. AIDS Education and Prevention 1995:7(1):22-31.

St. Lawrence JS, Brasfield TL, Jefferson KW, Alleyne E, O'Bannon RE, Shirley A. Cognitive behavioral intervention to reduce African-American adolescents' risk for HIV infection. Journal of Consulting and Clinical Psychology 1995;63(2):221-237.

St. Lawrence JS, Jefferson KW, Alleyne E, Brasfield TL. Journal of Consulting and Clinical Psychology 1995;53(1):154-157.

Stall R, Ostrow DG. Intravenous drug use, the combination of drugs and sexual activity and HIV infection among gay and bisexual men: the San Francisco Men's Health Study. Journal of Drug Issues 1989;19:57-73.

Stephens RC, Feucht TE, Roman SW. Effects of an intervention program on AIDS-related drug and needle behavior among intravenous drug users. American Journal of Public Health 1991;81(5):568-571.

Stryker J, Coates TJ, DeCarlo P, Haynes-Sanstad K, Shriver M, Makadon HJ. Prevention of HIV infection: looking back, looking ahead. JAMA 1995;273(14):1142-1148.

Sugarman K, Herman M. Crack cocaine and HIV in the inner city. [letter] New England Journal of Medicine 1995;332(18)1233-1234.

Susser E, Valencia E, Conover S. Prevalence of HIV infection among psychiatric patients in a New York City men's shelter. American Journal of Public Health 1993;83(4):568-570.

Thomas SB, Quinn SC. The burdens of race and history on Black Americans' attitudes toward needle exchange policy to prevent HIV disease. Journal of Public Health Policy 1993;14(3):320-347.

Trotter RT, Bowen AM, Potter JM Jr. Network models for HIV outreach and prevention programs for drug users. In: Needle RH, Coyle SL, Genser SG, Trotter RT, editors. National Institute on Drug Abuse research monograph 151: social networks, drug abuse, and HIV transmission. Rockville (MD): National Institute on Drug Abuse; 1995. NIH Publication No. 95-3889.

U.S. Department of Justice (DOJ), Bureau of Justice Statistics. HIV in prisons 1994. Bureau of Justice Statistics Bulletin. Washington (DC): U.S. Department of Justice; 1996 March.

U.S. Department of Justice (DOJ), Bureau of Justice Statistics. Survey of state prison inmates, 1991. Washington (DC): U.S. Department of Justice; 1993 March.

U.S. Department of Justice (DOJ), Office of Justice Programs, National Institute of Justice. Update: HIV/AIDS and STDs in correctional facilities, 1994. Washington (DC): U.S. Department of Justice; 1994.

U.S. House of Representatives, Committee on Government Relations. Drug treatment: despite new strategy, few federal inmates receive treatment: report to the Committee on Government Operations. Washington (DC): U.S. General Accounting Office; 1991 September. GAO/HRD-91-128.

Vanichseni S, Des Jarlais DC, Choopanya K, Friedman P, Wenston J, Sonchai W, Sotheran JL, Raktham S, Carballo M, Friedman SR. Condom use with primary partners among injecting drug users in Bangkok, Thailand and New York City, United States. AIDS 1993:7(6):887-891.

Vlahov D. Role of needle exchange programs in AIDS prevention. In: NIH Consensus Development Conference: interventions to prevent HIV risk behaviors, program and abstracts. 1997 Feb 11-13; Bethesda (MD):p.87-92.

Waldorf D. Drug use and HIV risk among male sex workers: Results of two samples in San Francisco. In: Battjes RJ, Sloboda Z, Grace WC, editors. National Institute on Drug Abuse research monograph 143: the context of HIV risk among drug users and their sexual partners. Rockville (MD): National Institute on Drug Abuse; 1994. NIH Pub. No. 95-3750.

Watters JK, Estillo MJ, Clark GL, Lorvick J. Syringe and needle exchange as HIV prevention for injection drug users. JAMA 1994;271(2):115-120.

Watters JK, Guydish J. HIV/AIDS prevention for drug users in natural settings. In: DiClemente RJ, Peterson JL, editors. Preventing AIDS: theories and methods of behavioral interventions. New York: Plenum Press; 1994.

Weissman G, Brown V. Drug-using women and HIV: risk-reduction and prevention issues. In: O'Leary A, Jemmott LS (editors). Women at risk: issues in primary prevention of AIDS. New York: Plenum Publishing Corporation; 1995.

Weibel WW. The indigenous leader outreach model: intervention manual. Rockville (MD): National Institute on Drug Abuse; 1993. NIH Publication No. 93-3581.

Weibel WW, Jimenez A, Johnson W, Ouellet L, Jovanovic B, Lampinen T, Murray J, O'Brien MU. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 1996;12(3):282-289.

Williams ML, Zhuo Z, Siegal HA, Robles RR, Trotter RT III, Jones A. A comparison of drug use networks across three cities. In: Needle RH, Coyle SL, Genser SG, Trotter RT III, editors. NIDA research monograph series 151: social networks, drug abuse, and HIV transmission. Rockville (MD): National Institute on Drug Abuse; 1995. NIH Publication No. 95-3889.

Williams T. Crackhouse. New York: Addison-Wesley; 1993.

Woody GE, Donnell D, Metzger D, Marmor, M, Gross M, McKirnan D, Koblin BA, Seage G, Buchbinder S, Stone B. Substance use and risky behavior among men who have sex with men. Poster presented at the XI International Conference on AIDS; 1996 July 7-12; Vancouver, Canada.

Worth D. Sexual decision making and AIDS: why condom promotion among vulnerable women is likely to fail. Studies in Family Planning 1989;20(6 Pt 1):297-307.

View PDFPDF Icon

This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content.

   
Go to top

Privacy Policy | Accessibility

USA.gov: The U.S. Government's Official Web Portal